Achieve Life Sciences, Inc., a clinical-stage pharmaceutical company, develops and commercializes smoking cessation aids in the United States and internationally.
The last earnings update was 5 days ago.
Value is all about what a company is worth versus what price it is
available for. If you went into a grocery store and all the bananas were on sale
at half price, they could be considered
INTRINSIC VALUE BASED ON FUTURE CASH FLOWS
It is not possible to calculate the future cash flow value for
Achieve Life Sciences. This is due to cash flow or dividend data being
unavailable. The share price is
PRICE RELATIVE TO MARKET
We can also value a company based on what the stock market is willing to pay for
it. This is similar to the price of fruit (e.g. Mangoes or Avocados) increasing
when they are out of season, or how much your home is worth.
The amount the stock market is willing to pay for
Achieve Life Sciences's
is considered below, and whether this is a fair price.
Price based on past earnings
Achieve Life Sciences's earnings available for a low price, and how does
this compare to other companies in the same industry?
Achieve Life Sciences's earnings are expected to grow significantly at over 20% yearly.
Unable to determine if Achieve Life Sciences is high growth as no revenue estimate data is available.
Past and Future Earnings per Share
The accuracy of the analysts who estimate the future performance data can
be gauged below. We look back 3 years and see if they were any good at
predicting what actually occurred. We also show the highest and lowest estimates
looking forward to see if there is a wide range.
Achieve Life Sciences's performance over the past 5 years by checking for:
Has earnings increased in past 5 years? (1 check)
Has the earnings growth in the last year exceeded that of the
industry? (1 check)
Is the recent earnings growth over the last year higher than the average annual growth over the
past 5 years? (1 check)
Is the Return on Equity (ROE) higher than 20%? (1 check)
Is the Return on Assets (ROA) above industry average? (1 check)
Has the Return on Capital Employed (ROCE) increased from 3 years ago? (1 check)
The above checks will fail if the company has reported a loss in the most recent
earnings report. Some checks require at least 3 or 5 years worth of data.
Achieve Life Sciences
has a total score of
0/6, see the detailed checks below.
Note: We use GAAP Net Income excluding extraordinary items in all our calculations.
A company's financial position is much like your own financial position,
it includes everything you own
The boxes below represent the relative size of what makes up
Achieve Life Sciences's finances.
The net worth of a company is the difference between its assets and liabilities.
Achieve Life Sciences is able to meet its short term (1 year) commitments with its holdings of cash and other short term assets.
Achieve Life Sciences's cash and other short term assets cover its long term commitments.
This treemap shows a more detailed breakdown of
Achieve Life Sciences's finances. If any of them are yellow this
indicates they may be out of proportion and red means they relate to one of the
Liabilities and shares
The 'shares' portion represents any funds contributed by the owners (shareholders) and any profits.
Low level of unsold assets.
Debt is covered by short term assets, assets are 21.1x debt.
Nearly all companies have debt. Debt in itself isn’t
however if the debt is too high, or the company can’t afford to pay the interest
on its debts this may have impacts in the future.
The graphic below shows equity (available funds) and debt, we ideally want to
see the red area (debt) decreasing.
If there is any debt we look at the companies capability to repay it, and
whether the level has increased over the past 5 years.
Management is one of the most important areas of a company. We look at
unreasonable CEO compensation, how long the team and board of directors have
been around for and insider trading.
TENURE AS CEO
Dr. Richard A. B. Stewart, also known as Rick, has been Chairman, Chief Executive Officer and Director of Achieve Life Sciences, Inc. since August 2017. Dr. Stewart has been a Founder of Ricanto Limited, a pharmaceutical asset optimization company, since 2009. Dr. Stewart has been Chairman and Chief Executive Officer of Renown Pharma Limited since 2016. Dr. Stewart serves as Financial Strategic & Operational Advisor for Avicena Group Inc. He served as Chief Executive Officer of OncoGenex Pharmaceuticals, Inc. He served as Chairman and Chief Executive Officer of Huxley Pharmaceuticals, Inc. since 2009. Dr. Stewart served as Chief Executive Officer of Brabant Pharma Limited from 2013 to 2014. Dr. Stewart served as Chief Executive Officer of Amarin Corporation plc from November 23, 1998 to December 19, 2007 and was its Founder. Dr. Stewart joined Amarin Corp. PLC in November 1998 and served as its President and Chief Operating Officer. He served as Executive Director of Amarin Corporation plc since November 23, 1998. He was responsible for corporate strategy as Corporate Development Director of SkyePharma PLC and served as its Finance Director. Dr. Stewart was a Co-Founder of SkyePharma plc and served as its Chief Financial Officer and Chief Business Officer from 1995 to 1998. He served as the Chairman of OncoGenex Pharmaceuticals, Inc. since August 1, 2017. He has been a Director of Ricanto Limited, a pharmaceutical asset optimization company, since 2009. He serves as Director of Avicena Group Inc. He served as Director of SkyePharma plc. Dr. Stewart holds a B.S. in Business Administration from the University of Bath, School of Management.
Rick's compensation has increased whilst company is loss making.
Rick's remuneration is higher than average for companies of similar size in United States of America.
Management Team Tenure
Average tenure and age of the
Achieve Life Sciences
management team in years:
The tenure for the Achieve Life Sciences management team is about average.
Chairman of the Board & CEO
Executive VP & Chief Medical Officer
Executive Vice President of Commercial
Board of Directors Tenure
Average tenure and age of the
Achieve Life Sciences
board of directors in years:
The tenure for the Achieve Life Sciences board of directors is about average.
Imagine Owning Achieve Life Sciences And Trying To Stomach The 75% Share Price Drop
Over the last month the Achieve Life Sciences, Inc. … Achieve Life Sciences didn't have any revenue in the last year, so it's fair to say it doesn't yet have a proven product (or at least not one people are paying for). … It certainly is a dangerous place to invest, as Achieve Life Sciences investors might realise.
Could Achieve Life Sciences Inc's (NASDAQ:ACHV) Investor Composition Influence The Stock Price?
Every investor in Achieve Life Sciences Inc (NASDAQ:ACHV) should be aware of the most powerful shareholder groups. … With a market capitalization of US$12m, Achieve Life Sciences is a small cap stock, so it might not be well known by many institutional investors. … See our latest analysis for Achieve Life Sciences
Who Are The Largest Shareholders In Achieve Life Sciences Inc (NASDAQ:ACHV)?
This size of ownership gives retail investors collective power in deciding on major policy decisions such as executive compensation, appointment of directors and acquisitions of businesses. … Private Company Ownership Another important group of owners for potential investors in ACHV are private companies that hold a stake of 0.13% in ACHV. … Thus, investors not need worry too much about the consequences of these holdings.Next Steps: Institutional ownership in ACHV is not at a level that would concern investors.
Why Achieve Life Sciences Inc's (NASDAQ:ACHV) Investor Composition Impacts Your Returns
Check out our latest analysis for Achieve Life Sciences NasdaqCM:ACHV Ownership_summary Jan 11th 18 Institutional Ownership Institutional investors are one of the largest group of market participants and their buy-sell decisions on a company's stock can significantly impact prices, more so, when there are relatively small amounts of shares available on the market to trade. … Insider Ownership Another important group of shareholders are company insiders. … Insider ownership has to do more with how the company is managed and less to do with the direct impact of the magnitude of shares trading on the market.
Achieve Life Sciences Inc (ACHV) And The Healthcare Industry Prospect For 2017
The demand for new drug development to meet new or persistent chronic illnesses, as well as the ongoing need for biotech drugs as Baby Boomers continue to age, are growth drivers for the optimistic outlook for the biotech industry in the long run. … This rate is larger than the growth rate of the US stock market as a whole. … Given the lack of analyst consensus in ACHV’s outlook, we could potentially assume the stock’s growth rate broadly follows its biotech industry peers.
Achieve Life Sciences, Inc., a clinical-stage pharmaceutical company, develops and commercializes smoking cessation aids in the United States and internationally. The company offers cytisinicline, a plant-based alkaloid that interacts with nicotine receptors in the brain to help reduce the severity of nicotine withdrawal symptoms. It has a license agreement with Sopharma AD and University of Bristol. The company is based in Vancouver, Canada.
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.